Related Experiment Video
Updated: May 21, 2026

Measuring the Stiffness of Ex Vivo Mouse Aortas Using Atomic Force Microscopy
Published on: October 19, 2016
Association between human cartilage glycoprotein 39 (YKL-40) and arterial stiffness in essential hypertension
Wei-hong Ma1, Xiu-ling Wang, Yi-meng Du
1Department of Cardiology, The Second Hospital of Shandong University, Jinan, 250033, China.
Insights
Elevated YKL-40 levels are linked to increased arterial stiffness in hypertensive patients. This suggests YKL-40 may contribute to vascular complications in essential hypertension.
Area of Science:
- Cardiovascular Research
- Biomarker Discovery
- Hypertension Studies
Background:
- YKL-40 is a proposed marker for inflammation and endothelial dysfunction.
- It is associated with atherosclerosis and cardiovascular mortality in the general population.
- The link between YKL-40 and arterial stiffness in hypertension is not well-established.
Purpose of the Study:
- To investigate the relationship between serum YKL-40 levels and arterial stiffness in essential hypertensive patients.
- To assess YKL-40 as a potential biomarker for vascular complications in hypertension.
Main Methods:
- Serum YKL-40 levels were measured using ELISA in 93 hypertensive and 80 normotensive subjects.
- Arterial stiffness was assessed via femoral arterial stiffness and carotid-femoral pulse wave velocity (cf-PWV).
- Hypertensive subjects were stratified by urinary albumin-to-creatinine ratio (ACR).
Main Results:
- YKL-40, cf-PWV, and femoral arterial stiffness were significantly higher in hypertensive versus normotensive individuals.
- These markers were also elevated in hypertensive patients with microalbuminuria compared to those without.
- YKL-40 showed a significant positive correlation with cf-PWV and femoral arterial stiffness.
Conclusions:
- Serum YKL-40 levels are elevated in essential hypertension.
- There is an independent association between higher YKL-40 levels and increased arterial stiffness.
- YKL-40 may play a role in the progression of vascular complications in essential hypertension.
Background:
YKL-40, a proposed marker of inflammation and endothelial dysfunction, is associated with atherosclerosis and an increased cardiovascular mortality in the general population. However, the relationship between YKL-40 and arterial stiffness in hypertensive patients has not been adequately assessed.
Methods:
The relationship between serum levels of YKL-40 and arterial stiffness was evaluated in 93 essential hypertensive subjects and 80 normal subjects. Essential hypertensive subjects were divided into two groups based upon urinary albumin-to-creatinine ratio (ACR): nonmicroalbuminuric group, (ACR <30 mg/g, n = 50) and microalbuminuric group (ACR ≥ 30 mg/g, n = 43). Large artery wall stiffness was assessed by measuring femoral arterial stiffness and carotid-femoral pulse wave velocity (cf-PWV). Serum levels of YKL-40 were determined by enzyme-linked immunosorbent assay (ELISA).
Results:
The study demonstrated that YKL-40,cf-PWV and femoral arterial stiffness were increased significantly (P<0.05) in the hypertensive group compared with normal controls. These measurements were also increased significantly ( P<0.05) in the microalbuminuric group compared with the nonmicroalbuminuric group. YKL-40 was positively correlated with cf-PWV( r = 0.44, P = 0.000) and femoral arterial stiffness ( r = 0.42, P =0.001). Multiple linear stepwise regression analysis showed that YKL-40 was the impact factor of arterial stiffness ( P<0.05).
Conclusion:
YKL-40 levels are elevated in essential hypertension subjects with an independent association between increasing YKL-40 levels and increasing arterial stiffness. The study suggests it played a positive role of YKL-40 in the progressing vascular complications in patients with essential hypertension.
Related Concept Videos
Hypertension II: Pathophysiology
Hypertension and Regulation of Blood Pressure
Hypertension III: Clinical Manifestations and Diagnostic Studies
Hypertension I: Introduction
Factors affecting Blood pressure
Physiological Factors:
